BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 32548891)

  • 1. A COBRA for stomata.
    Trösch R
    Nat Plants; 2023 Nov; 9(11):1781. PubMed ID: 37935989
    [No Abstract]   [Full Text] [Related]  

  • 2. Design and Rationale of a Randomized Trial of COBRA PzF Stenting to REDUCE Duration of Triple Therapy (COBRA-REDUCE).
    Colleran R; Joner M; Cutlip D; Urban P; Maeng M; Jauhar R; Barakat M; Michel JM; Mehran R; Kirtane AJ; Maillard L; Kastrati A; Byrne RA;
    Cardiovasc Revasc Med; 2022 Jan; 34():17-24. PubMed ID: 33608239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latest-iteration balloon- and self-expandable transcatheter valves for severe bicuspid aortic stenosis: the TRITON study.
    Amat-Santos IJ; García-Gómez M; de Marco F; Won-Keun K; Brito J; Halim J; Jose J; Sengotuvelu G; Seth A; Terkelsen C; Protasiewicz M; Bonilla N; García B; Sánchez-Luna JP; Blasco-Turrión S; González JC; González-Bartol E; Ijsselmuiden AJJ; Gómez-Salvador I; Carrasco Moraleja M; San Román A
    Rev Esp Cardiol (Engl Ed); 2023 Nov; 76(11):872-880. PubMed ID: 36898524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Assessment of Thin-Strut BioMime Coronary Stent System in Real-World Population at Single-Center: A Retrospective Observational Study.
    Meennahalli Palleda G; Gupta M; Bansal A; Batra V; Tyagi S; Kunal S
    Cardiol Res; 2023 Oct; 14(5):360-369. PubMed ID: 37936627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomedicine for Diagnosis and Treatment of Atherosclerosis.
    Cheng J; Huang H; Chen Y; Wu R
    Adv Sci (Weinh); 2023 Dec; 10(36):e2304294. PubMed ID: 37897322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biofunctionalization of cardiovascular stents to induce endothelialization: Implications for in- stent thrombosis in diabetes.
    Marei I; Ahmetaj-Shala B; Triggle CR
    Front Pharmacol; 2022; 13():982185. PubMed ID: 36299902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in Nanomaterials for Injured Heart Repair.
    Guo J; Yang Z; Wang X; Xu Y; Lu Y; Qin Z; Zhang L; Xu J; Wang W; Zhang J; Tang J
    Front Bioeng Biotechnol; 2021; 9():686684. PubMed ID: 34513807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface engineering at the nanoscale: A way forward to improve coronary stent efficacy.
    Cherian AM; Nair SV; Maniyal V; Menon D
    APL Bioeng; 2021 Jun; 5(2):021508. PubMed ID: 34104846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Simulated COVID-19 Cytokine Storm on Stent Thrombogenicity.
    Cornelissen A; Kutyna M; Cheng Q; Sato Y; Kawakami R; Sakamoto A; Kawai K; Mori M; Fernandez R; Guo L; Pellegrini D; Guagliumi G; Barakat M; Virmani R; Finn A
    Cardiovasc Revasc Med; 2022 Feb; 35():129-138. PubMed ID: 33863660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in nanomaterials for therapy and diagnosis for atherosclerosis.
    Chen J; Zhang X; Millican R; Sherwood J; Martin S; Jo H; Yoon YS; Brott BC; Jun HW
    Adv Drug Deliv Rev; 2021 Mar; 170():142-199. PubMed ID: 33428994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MAPT (Mono Antiplatelet Therapy) as Regular Regimen After COBRA PzF™ NanoCoated Coronary Stent (NCS) Implantation.
    Maillard L; Vochelet F; Peycher P; Ayari A; Barra N; Billé J; Joly P; Silvestri M; Sévilla J; Tavildari A
    Cardiovasc Revasc Med; 2020 Jun; 21(6):785-789. PubMed ID: 31780418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immediate and 1-year follow-up with the novel nanosurface modified COBRA PzF stent.
    Maillard L; Tavildari A; Barra N; Billé J; Joly P; Peycher P; Silvestri M; Vochelet F
    Arch Cardiovasc Dis; 2017 Dec; 110(12):682-688. PubMed ID: 29102364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five-Year Clinical Outcomes of the COBRA Polyzene F NanoCoated Coronary Stent System.
    Cutlip DE; Jauhar R; Meraj P; Garratt KN; Novack V; Novack L; Maillard L; Erglis A; Stoler R; Barakat M; Silber S;
    Cardiovasc Revasc Med; 2022 Aug; 41():76-80. PubMed ID: 35045942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COBRA PzF™ coronary stent in clinical and preclinical studies: setting the stage for new antithrombotic strategies?
    Cornelissen A; Sakamoto A; Sato Y; Kawakami R; Mori M; Kawai K; Kutyna M; Fernandez R; Ghosh S; Barakat M; Virmani R; Finn A
    Future Cardiol; 2022 Mar; 18(3):207-217. PubMed ID: 34521223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the safety and efficacy of a Polyzene-F nanocoated coronary stent system: A systematic review and single-arm meta-analysis.
    Bian J; Yang R; Wang D; Yu H; Liu Y; Liu Q
    Front Cardiovasc Med; 2023; 10():1095794. PubMed ID: 37008338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the safety and efficacy of the Cobra PzF NanoCoated coronary stent in routine, consecutive, prospective, and high-risk patients: The e-Cobra study.
    Maillard L; de Labriolle A; Brasselet C; Faurie B; Durel N; de Poli F; Bosle S; Madiot H; Berland J; Belle L
    Catheter Cardiovasc Interv; 2021 Jul; 98(1):45-54. PubMed ID: 32548891
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.